Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 4,386,300 | 4,348,000 | 3,722,800 | 3,435,300 | 2,963,700 |
| Cost of Goods | 1,080,600 | 1,114,400 | 939,400 | 875,300 | 797,400 |
| Gross Profit | 3,305,700 | 3,233,600 | 2,783,400 | 2,560,000 | 2,166,300 |
| Operating Expenses | 2,408,700 | 2,087,200 | 2,035,600 | 1,470,900 | 1,382,900 |
| Operating Income | 897,600 | 1,146,800 | 748,200 | 1,089,400 | 783,800 |
| Interest Expense | 15,800 | 20,700 | 29,900 | 23,200 | 19,200 |
| Other Income | 34,900 | 40,400 | 43,100 | -31,300 | -26,700 |
| Pre-tax Income | 916,700 | 1,166,500 | 761,400 | 1,034,900 | 737,900 |
| Income Tax | 93,300 | 119,600 | 39,200 | 451,300 | 168,400 |
| Net Income Continuous | 823,400 | 1,046,900 | 722,200 | 583,600 | 569,500 |
| Net Income | $823,400 | $1,046,900 | $722,200 | $583,600 | $569,500 |
| EPS Basic Total Ops | 1.32 | 1.68 | 1.15 | 0.92 | 0.89 |
| EPS Basic Continuous Ops | 1.32 | 1.68 | 1.15 | 0.92 | 0.89 |
| EPS Diluted Total Ops | 1.30 | 1.64 | 1.13 | 0.90 | 0.87 |
| EPS Diluted Continuous Ops | 1.30 | 1.64 | 1.13 | 0.90 | 0.87 |
| EPS Diluted Before Non-Recurring Items | 1.86 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $1,004,800 | $1,236,100 | $825,600 | $1,171,300 | $855,000 |